Catalin Toma
Latest contributions
LAA closure and pulmonary embolism hotline
22 May 2026 – From EuroPCR 2026
Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.
Pulmonary embolism intervention: a turning point in defining success
21 May 2026 – From EuroPCR 2026
This session explores the evolving objectives of pulmonary embolism treatment, highlighting the shift from simple patient stabilisation to a more comprehensive approach to recovery. It introduces the novel Transforming Fixation (TFX) technology and its role in improving catheter stability and access to the pulmonary vasculature. Drawing...
All you need to know about interventional therapies for pulmonary embolism
20 May 2026 – From EuroPCR 2026
Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.
Large-bore thrombectomy in pulmonary embolism practice: when intervention matters
20 May 2026 – From EuroPCR 2026
Management of pulmonary embolism is increasingly shifting toward interventional strategies, where timing, patient selection and procedural expertise play a central role in improving outcomes.
Large-bore thrombectomy is examined as a key option within contemporary PE treatment, focusing on when intervention is most appropriate and how to optimise...
Complex endovascular and pulmonary interventions
20 May 2026 – From EuroPCR 2026
Explore advances in complex endovascular and pulmonary interventions, including the transformation of interventional labs into intelligent learning ecosystems, innovative approaches to peripheral and coronary CTOs, and novel therapies such as extravascular renal denervation and fixation catheters for acute pulmonary embolism.
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
Challenging scenarios in the pulmonary system - Part 1
21 May 2025 – From EuroPCR 2025
This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.
Catheter-based treatment of pulmonary embolism
20 May 2025 – From EuroPCR 2025
Explore catheter-based interventions for pulmonary embolism, addressing high-risk and massive thrombus cases, management of severe complications, and clinical scenarios involving multiple concurrent challenges to optimize patient care and procedural success.
Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, study the case of a patient with high-risk pulmonary embolism and another with intermediate to high-risk pulmonary embolism, delve into discussions on clinical evidence for mechanical thrombectomy in pulmonary embolism, acquire skills to evaluate eligibility for mechanical thrombectomy, and learn how to...
Thrombectomy for pulmonary embolism
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on catheter-directed therapy for pulmonary embolism. It includes presentations and discussions on an intelligent CT vacuum aspiration thrombectomy system, outcomes of catheter-directed therapy in intermediate-high and high-risk pulmonary embolism, and functional and quality of life outcomes in...
Is the invasive treatment of pulmonary embolism ready for prime time?
17 May 2023 – From EuroPCR 2023
In many parts of the world, pulmonary embolism is not a field traditionally reserved for cardiologists, but Catalin Toma and Andrew Sharp explain why they should be involved in its treatment.
As it is an RV failure problem that evolves from subclinical to frank shock, given that cardiologists...
Current trends in the invasive treatment of pulmonary embolism
18 May 2023 – From EuroPCR 2023
Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...
Interventional options
17 May 2023 – From EuroPCR 2023
Enhance your understanding of pulmonary embolism management: Delve into a comprehensive selection of clinical cases and abstracts that provide in-depth analysis and commentary on interventional approaches, enabling you to grasp the intricacies of managing complications effectively.
Aorta, pulmonary and peripheral artery disease
17 May 2022 – From EuroPCR 2022
Watch these videos on aorta, pulmonary and peripheral artery disease to learn more about the catheter-directed therapy for the treatment of high-risk pulmonary embolism, the clinical evidence for pulmonary embolism treatment with mechanical thrombectomy, the revascularisation strategies in patients with peripheral arterial disease, and more!
